EU Gets Go-Ahead To Negotiate Global Pandemic Treaty
CEPI Fundraising Event Taking Place This Week
Executive Summary
The process of drafting an international agreement on pandemic preparedness and response is picking up speed, although one NGO has warned that this must not distract from more immediate priorities such as technology transfer for producing COVID-19 medical products.
You may also be interested in...
Coronavirus Notebook: Hearings On Pandemic Treaty Begin, New Risk-Sharing Partnership To Boost COVAX Efforts
Médecins Sans Frontières says the latest draft of the proposed IP waiver must be rejected, and the WHO has suspended supply of Bharat’s COVID-19 vaccine over manufacturing issues. Two EU agencies have issued advice on fourth doses of mRNA vaccines, while GlaxoSmithKline has filed high-dose sotrovimab for patients with suspected Omicron BA.2 infection in Australia.
New EU Body To Deal With COVID-19 Vaccine Strategy & Procurement
Europe is stepping up its efforts to prepare for future health crises. A new parliamentary committee will look at how to make the most of the lessons learned from the coronavirus pandemic, while EU health ministers will next week discuss “vaccine solidarity” and the draft regulation on cross-border threats to health.
G20 Health Threats Fund Needs More Clout, WHO’s C-TAP Underused
Numerous initiatives are under way to maximize equitable access to COVID-19 products around the world, but most have some drawbacks that need to be addressed if they are to meet their goals, according to the medicines access NGO, WEMOS.